Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Miragen Therapeutics Inc (NASDAQ:MGEN)

7.55
Delayed Data
As of 4:00pm ET
 +0.18 / +2.44%
Today’s Change
4.65
Today|||52-Week Range
18.00
+50.70%
Year-to-Date

Today’s Trading

Previous close7.37
Today’s open7.40
Day’s range7.36 - 7.69
Volume134,584
Average volume (3 months)88,929
Market cap$164.4M
Data as of 4:00pm ET, 12/13/2017

Growth & Valuation

Earnings growth (last year)+16.34%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+31.48%
P/E ratio50.3
Price/Sales1.08
Price/Book--

Competitors

 Today’s
change
Today’s
% change
FOMXFoamix Pharmaceutica...+0.19+3.29%
NYMXNymox Pharmaceutical...+0.24+7.08%
CKPTCheckpoint Therapeut...+0.11+2.22%
MNOVMediciNova Inc+0.62+10.02%
Data as of 4:00pm ET, 12/13/2017

Financials

Next reporting dateMarch 15, 2018
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$3.3M
Annual profit (last year)-$12.7M
Net profit margin-379.80%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
William S. Marshall
Chief Financial Officer, Secretary &
Treasurer
Jason A. Leverone
Corporate headquarters
Boulder, Colorado

Forecasts